Non-regulatory press release

Prostatype Genomics changes Certified Adviser to Erik Penser Bank AB

Prostatype Genomics AB (publ) announces today that the company is changing its Certified Adviser.

Prostatype Genomics has entered into an agreement with Erik Penser Bank regarding the position as Certified Adviser. Erik Penser Bank takes office as Certified Adviser as of August 28th. Until then, Svensk Kapitalmarknadsgranskning will continue to act as Certified Adviser for the company.

Company contact

Fredrik Persson, CEO
fredrik.persson@prostatypegenomics.com

Certified Advisor

Svensk Kapitalmarknadsgranskning AB, www.skmg.se

Prostatype® is a genetic test that is available to patients and treating urologists as a complementary decision basis for the question of treatment or non-treatment of prostate cancer. The test was developed by a research group at Karolinska Institutet and is provided by Prostatype Genomics AB.